Use of PSMA PET in metastatic castration-resistant prostate cancer (mCRPC)

被引：0
|
作者：
Karunaratna, Nathasha
Jensen, Andrew
Wong, Shirley
Shapiro, Julia
Weickhardt, Andrew
Spain, Lavinia
Azad, Arun
Kwan, Edmond M.
Muthusamy, Arun
Torres, Javier
Parente, Phillip
Parnis, Francis
Goh, Jeffrey
Gibbs, Peter
Tran, Ben
Anton, Angelyn
机构：
来源：
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 16卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
abs47
引用
收藏
页码：58 / 58
页数：1
相关论文
共 50 条
  • [21] Modulation of plasma lipidomic signature in metastatic castration-resistant prostate cancer (mCRPC).
    Mak, Blossom
    Mahon, Kate Lynette
    Stockler, Martin R.
    Joshua, Anthony M.
    Zhang, Alison Yan
    Parnis, Francis
    Meikle, Peter
    Horvath, Lisa
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (07)
  • [22] Pembrolizumab in men with heavily treated metastatic castration-resistant prostate cancer (mCRPC).
    Tucker, Matthew D.
    Zhu, Jason
    Berry, William R.
    Ramalingam, Sundhar
    Zhang, Tian
    Harrison, Michael Roger
    Wu, Yuan
    Healy, Patrick
    George, Daniel J.
    Armstrong, Andrew J.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (07)
  • [23] Phase II Study with metastatic castration-resistant Prostate Cancer (mCRPC) Patients
    Rexer, H.
    Graefen, M.
    UROLOGE, 2017, 56 (11): : 1468 - 1470
  • [24] Cytotoxic chemotherapy in the contemporary management of metastatic castration-resistant prostate cancer (mCRPC)
    Sonpavde, Guru
    Wang, Christopher G.
    Galsky, Matthew D.
    Oh, William K.
    Armstrong, Andrew J.
    BJU INTERNATIONAL, 2015, 116 (01) : 17 - 29
  • [25] INTERMITTENT (RECHALLENGE) CHEMOTHERAPY WITH DOCETAXEL IN METASTATIC CASTRATION-RESISTANT PROSTATE CANCER (MCRPC)
    Bracarda, Sergio
    Rossi, Marta
    Hamzaj, Alketa
    De Angelis, Verena
    De Simone, Valeria
    Caserta, Claudia
    Crino, Lucio
    ANNALS OF ONCOLOGY, 2009, 20
  • [26] Response Evaluation Criteria in PSMA PET/CT (RECIP 1.0) in Metastatic Castration-resistant Prostate Cancer
    Gafita, Andrei
    Djaileb, Loic
    Rauscher, Isabel
    Fendler, Wolfgang P.
    Hadaschik, Boris
    Rowe, Steven P.
    Herrmann, Ken
    Calais, Jeremie
    Rettig, Matthew
    Eiber, Matthias
    Weber, Manuel
    Benz, Matthias R.
    Farolfi, Andrea
    RADIOLOGY, 2023, 308 (01)
  • [27] Chemotherapy Use in Metastatic Castration Resistant Prostate Cancer (mCRPC) in the UK
    Jones, R.
    Harland, S.
    Mazhar, D.
    James, N.
    Mason, M.
    Peperell, K.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S499 - S499
  • [28] Metastatic castration-resistant prostate cancer
    Henriques, Vanessa
    Wenzel, Mike
    Demes, Melanie-Christin
    Koellermann, Jens
    PATHOLOGE, 2021, 42 (04): : 431 - 438
  • [29] PSMA PET-CT redefines nonmetastatic castration-resistant prostate cancer
    Ost, Piet
    NATURE REVIEWS UROLOGY, 2020, 17 (03) : 133 - 134
  • [30] Predictive and prognostic potential of pretreatment 68Ga-PSMA PET tumor heterogeneity index in patients with metastatic castration-resistant prostate cancer (mCRPC).
    Assadi, Majid
    Manafi-Farid, Reyhaneh
    Jafai, Esmail
    Keshavarz, Ahmad
    Divband, GhasemAli
    Moradi, Mohammad Mobin
    Adinehpour, Zohreh
    Samimi, Rezvan
    Dadgar, Habibollah
    Mayer, Benjamin
    Prasad, Vikas
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41
12345